Vulval cancerA study looking at how people manage symptoms that could be cancer (CLOCS-2)
This study is looking at the products people buy to help with vague symptoms that could be cancer.
Vulval cancer
Available
Available
A study looking at how bacteria in the gut affects treatment for pelvic cancer (PELICAN-23)
This study is looking to see if gut bacteria the microbiome affects how well treatment works for certain cancers that started in the pelvis.
Vulval cancer mortality projections
Vulval cancer mortality rates are projected to rise by 20% in the UK between 2023-2025 and 2038-2040.
There could be around around 870 deaths of vulval cancer every year in the UK by 2038-2040, projections suggest.
Vulval cancer incidence projections
Vulval cancer incidence rates are projected to rise by 5% in the UK between 2023-2025 and 2038-2040.
There could be around 2,000 new cases of vulval cancer every year in the UK by 2038-2040, projections suggest.
A trial looking at a new blood test to help diagnose cancer earlier (SYMPLIFY)
This study looked at a blood test called a multi cancer early detection (MCED) test. It is also called the Galleri test.
Vulval cancer survival by stage at diagnosis
When diagnosed at its earliest stage, more than 9 in 10 (96%) people with vulval cancer will survive their disease for one year or more, compared with more than 4 in 10 (43%) people when the disease is diagnosed at the latest stage.
Vulval cancer mortality by age
Mortality rates for vulval cancer in the UK are highest in females aged 90+ (2017-2019).
Each year more than two-thirds of all vulval cancer deaths (68%) in the UK are in females aged 75 and over (2017-2019).
A trial looking at pembrolizumab for people with advanced gynaecological cancer (PEACOCC)
This trial is for people with ovarian, womb, cervical, vaginal or vulval cancer.
A study looking at high intensity focal ultrasound for symptoms of women’s cancers (HIFU-Gynae)
This study looked at whether high intensity focused ultrasound (HIFU) is a useful treatment for symptoms of women’s cancer.
Vulval cancer mortality trends over time
Since the early 1970s, vulval cancer mortality rates have decreased by almost two-fifths (38%) in females in the UK (2017-2019).
Over the last decade, vulval cancer mortality rates have remained stable in females in the UK (2017-2019).